US approves Biogen Alzheimer’s drug in treatment landmark ...United Arab Emirates

Gulf News - News
US approves Biogen Alzheimer’s drug in treatment landmark
Washington: Biogen Inc. received approval for its controversial Alzheimer’s disease therapy, a landmark decision that stands to dramatically change treatment for the debilitating brain condition. After decades of research failures by numerous companies, Biogen’s aducanumab became the first drug cleared by the US Food and Drug Administration to slow the course of the mind-wasting disease that afflicts 6 million Americans. The antibody therapy, which will be sold under the brand name Aduhelm, works by removing amyloid, a harmful protein that clogs the brains of Alzheimer’s patients. The last new drug treatment for the disease was first approved in 2003; existing therapies help with symptoms b

Hence then, the article about us approves biogen alzheimer s drug in treatment landmark was published today ( ) and is available on Gulf News ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( US approves Biogen Alzheimer’s drug in treatment landmark )

Apple Storegoogle play

Last updated :

Also on site :